Coração carcinóide – a propósito de um caso clínico

Modlin, 1997, An analysis of 8305 cases of carcinoid tumors, Cancer, 79, 813, 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2 Kulke, 1999, Carcinoid tumors, N Engl J Med, 340, 858, 10.1056/NEJM199903183401107 Moller, 2005, Prognosis of carcinoid heart disease: Analysis of 200 cases over two decades, Circulation, 112, 3320, 10.1161/CIRCULATIONAHA.105.553750 Bhattacharyya, 2007, Carcinoid Heart Disease, Circulation, 116, 2860, 10.1161/CIRCULATIONAHA.107.701367 Lundin, 1988, Relationship of circulating vasoactive substances to ultrasound detectable cardiac abnormalities, Circulation, 77, 264, 10.1161/01.CIR.77.2.264 Pellikk, 1993, Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients, Circulation, 87, 1188, 10.1161/01.CIR.87.4.1188 Westberg, 2001, Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome, Br J Surg, 88, 865, 10.1046/j.0007-1323.2001.01798.x Bastarrika, 2005, Magnetic resonance imaging diagnosis of carcinoid heart disease, J Comput Assist Tomogr, 29, 756, 10.1097/01.rct.0000181724.69597.69 Korse, 2009, Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor, J Clin Oncol, 27, 4293, 10.1200/JCO.2008.18.7047